• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

OMG!!!! We are in big trouble in the Alzheimer's Division!

Quote












































I hope everyone in AD sales division realized it was a likely non approval and has a backup plan in place.

Or were they selling you koolaid and saying it was going to be approved?
 




















If you came from an established job and things were okay, it was a terribly wrong move. If you came because you needed a job, look at this as good experience and something you can now put on your resume. It is sad how companies play with so many people's lives when they can simply acquire people with a letter of intent to hire upon FDA approval. Then use the first three months to train and gather information from the marketplace. THEN proceed with a launch. Very logical. Why some of these companies don't do that is a wonder.

Hopefully, the FDA's decision to say no won't come until March and Biogen does give those they let go a decent package to allow time to find a new job. Approval isn't going to happen, but senior leadership really knows that.
 




anonymous said:
If you came from an established job and things were okay, it was a terribly wrong move. If you came because you needed a job, look at this as good experience and something you can now put on your resume. It is sad how companies play with so many people's lives when they can simply acquire people with a letter of intent to hire upon FDA approval. Then use the first three months to train and gather information from the marketplace. THEN proceed with a launch. Very logical. Why some of these companies don't do that is a wonder.

Hopefully, the FDA's decision to say no won't come until March and Biogen does give those they let go a decent package to allow time to find a new job. Approval isn't going to happen, but senior leadership really knows that.
Click to expand...

if anyone took this job coming from even a decent job, they are idiots. Most of those that ended up accepting were running from something and 3 or 4th choices of the hiring manager.

Biogen’s history suggests they couldn’t care less about these folks, so the severance and time will be minimal
 




anonymous said:
if anyone took this job coming from even a decent job, they are idiots. Most of those that ended up accepting were running from something and 3 or 4th choices of the hiring manager.

Biogen’s history suggests they couldn’t care less about these folks, so the severance and time will be minimal
Click to expand...

Although most of the information on this thread is very accurate. You are not. It is extremely obvious you were passed on and you are still stewing over it. Get over it sour grapes. They got the top performers, not 3rd or 4th choices. So get that straight. Your obsession and anger for not getting the job is getting the best of you. Some people took a shot to come here, but quickly realized after looking at the data closely, it was not a good idea.
 




anonymous said:
Hopefully, the FDA's decision to say no won't come until March
Click to expand...

If the panel is very clear in voting it down or not recommending approval, the FDA is going to likely to pounce very quickly if they want BIIB to start a new Phase 3 As soon as possible. They’re not going to let another 3-4 months burn just for the hell of it.
 




Top Bottom
Back
Quote